Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked

By Steve Macfarlane, Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower risk of dementia.

The researchers compared the health outcomes of more than 110,000 people aged 40–69 with type 2 diabetes who had been prescribed a type of drug called SGLT-2 inhibitors with those of another 110,000 patients taking a different class of drug, DPP-4 inhibitors. They followed participants for an average of 670 days.

The researchers…

Read complete article

~	UK public is becoming more ‘carbon capable’ – here’s what that means

~	The Trump-Harris debate shows how personality can reveal itself in language

~	Kyrgyz Police Go Unpunished for Failing to Protect Women

~	Protect future generations from global decisions made today

~	Chroming, choking and skull-breaking – social media challenges can come with deadly consequences

~	Research nation: whisper it, Europe still sometimes looks to the UK

~	Trump’s abortion flip-flops: Lessons from Ireland on why reasons-based access to abortion doesn’t work

~	In Lebanon, foreign investment soars despite ongoing challenges

~	Getting shorter and going hungrier: how children in the UK live today

~	Marine art deepens our understanding of the oceans – here’s how it has evolved through the centuries